Regulatory Changes
Expert articles and analysis related to regulatory changes.
AI Summary — Last 7 Days
In the last week, several states are advancing changes to their certificate-of-need (CON) laws, with active proposals in Maryland seeking to streamline healthcare facility development and mitigate redundancy in services. This shift reflects a growing tension between the need for healthcare expansion and cost management, which is crucial for Value-Based Care (VBC) stakeholders navigating an evolving regulatory landscape. Meanwhile, the FDA's unexpected rejection of a potentially game-changing cancer therapy underscores the challenges drugmakers face in securing timely approvals, which could impact treatment options for patients with rare diseases as well as future VBC initiatives. For more on state-level CON law changes, visit Becker's ASC, and for insights on FDA challenges, see Stat News.
Related Articles
The states where CON laws could change next
Several states are evaluating changes to their certificate-of-need laws and they look to balance the development and expansion of new healthcare services while avoiding repeated services and managing ...
Gastroenterology and private equity in 2026: 5 notes
Private equity’s presence in gastroenterology in 2026 is beginning to look different than it has in previous years as deals slow down in volume but grow in size. At the same time, PE groups and GI sta...
STAT+: A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA
Drugmakers thought they had the FDA's buy-in to approve a therapy to treat a type of cancer that can quickly turn deadly. The agency, however, rejected it.